Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literature

Fig. 1

Lung lesion biopsy results of the patient. “Lung”: biopsy of small tissue, combined with histology and immunohistochemistry, to support the diagnosis of small cell carcinoma. Immunohistochemistry: P40* (−), P53* (Diffuse strong +), P16* (Diffuse strong +), CK* (−), K7* (−), CD56* (+), CgA* (+), SYN* (+), CD45* (−), Ki-67*(+ , about 80%)

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947